- Home
- CEAD vs EDSA Comparison
CEAD vs EDSA Comparison
Compare CEAD & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- EDSA
- Stock Information
- Founded
- CEAD 2009
- EDSA 2015
- Country
- CEAD United States
- EDSA Canada
- Employees
- CEAD N/A
- EDSA N/A
- Industry
- CEAD Industrial Machinery/Components
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CEAD Industrials
- EDSA Health Care
- Exchange
- CEAD Nasdaq
- EDSA Nasdaq
- Market Cap
- CEAD 6.9M
- EDSA 6.2M
- IPO Year
- CEAD N/A
- EDSA N/A
- Fundamental
- Price
- CEAD $8.46
- EDSA $2.45
- Analyst Decision
- CEAD
- EDSA Strong Buy
- Analyst Count
- CEAD 0
- EDSA 1
- Target Price
- CEAD N/A
- EDSA $21.00
- AVG Volume (30 Days)
- CEAD 22.9K
- EDSA 32.2K
- Earning Date
- CEAD 03-27-2025
- EDSA 05-09-2025
- Dividend Yield
- CEAD N/A
- EDSA N/A
- EPS Growth
- CEAD N/A
- EDSA N/A
- EPS
- CEAD N/A
- EDSA N/A
- Revenue
- CEAD $2,803,470.00
- EDSA N/A
- Revenue This Year
- CEAD N/A
- EDSA N/A
- Revenue Next Year
- CEAD N/A
- EDSA N/A
- P/E Ratio
- CEAD N/A
- EDSA N/A
- Revenue Growth
- CEAD N/A
- EDSA N/A
- 52 Week Low
- CEAD $5.60
- EDSA $1.55
- 52 Week High
- CEAD $12.26
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- CEAD 49.33
- EDSA 53.34
- Support Level
- CEAD $7.90
- EDSA $2.31
- Resistance Level
- CEAD $9.45
- EDSA $2.55
- Average True Range (ATR)
- CEAD 0.86
- EDSA 0.12
- MACD
- CEAD 0.06
- EDSA -0.02
- Stochastic Oscillator
- CEAD 63.44
- EDSA 48.28
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.